Rituximab and dose-dense chemotherapy for adults with Burkitt's lymphoma: a randomised, controlled, open-label, phase 3 trialVincent Ribrag, Gilles Salles, Christian Récher et al.|The Lancet|2016Cited by 190
A <scp>P</scp>hase 2 study of <scp>L</scp>‐asparaginase encapsulated in erythrocytes in elderly patients with <scp>P</scp>hiladelphia chromosome negative acute lymphoblastic leukemia: The <scp>GRASPALL/GRAALL‐SA</scp>2‐2008 studyMathilde Hunault, Hervé Dombret, Thibaut Leguay et al.|American Journal of Hematology|2015Cited by 78
High-dose imatinib mesylate combined with vincristine and dexamethasone (DIV regimen) as induction therapy in patients with resistant Philadelphia-positive acute lymphoblastic leukemia and lymphoid blast crisis of chronic myeloid leukemiaDelphine Réa, Philippe Rousselot, Laurence Legros et al.|Leukemia|2006Cited by 77